Clinical Trials on Solid Tumor (Excluding CNS) in United Kingdom
Total 3092 results
-
CTI BioPharmaWithdrawnLymphoma | Solid Tumor (Excluding CNS)United States
-
Children's Oncology GroupCompletedRefractory or Recurrent Solid Tumors, Excluding CNS TumorsUnited States, Canada
-
St. Jude Children's Research HospitalRecruitingSolid Tumor | CNS Tumor | ALL, AdultUnited States
-
Taiho Oncology, Inc.CompletedAdvanced Solid Tumors (Excluding Breast Cancer)United States
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors, Excluding Breast CancerNetherlands, Switzerland, Denmark, United States
-
Blueprint Medicines CorporationRecruitingCNS Tumor | Solid Tumor, Unspecified, Child | Relapsed Solid NeoplasmUnited States, Korea, Republic of, United Kingdom, France, Canada, Australia, Austria, Germany, Italy
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Excluding Breast CancerUnited States
-
National Cancer Institute (NCI)RecruitingSolid Tumor | Refractory Solid Tumors | Malignant Solid Tumors | Other Neoplasms Solid Tumors | Pediatric Solid TumorUnited States
-
Eli Lilly and CompanyChildren's Oncology GroupCompletedRecurrent Tumor | Pediatric Solid Tumor | Refractory Tumor | CNS MalignanciesUnited States
-
Genentech, Inc.CompletedSolid TumorUnited Kingdom
-
AstraZenecaCompletedAdvanced Solid Metastatic TumorUnited Kingdom
-
Leucid BioRecruitingTumor, SolidUnited Kingdom
-
University College, LondonImperial College London; Cancer Research UK; National Cancer Imaging Translational...RecruitingCancer | Tumor, SolidUnited Kingdom
-
Royal Marsden NHS Foundation TrustRecruitingSolid Tumor, AdultUnited Kingdom
-
Turning Point Therapeutics, Inc.RecruitingLymphoma | Locally Advanced Solid Tumors | Metastatic Solid Tumors | Primary CNS TumorsUnited States, Korea, Republic of, Spain, Singapore, Taiwan, Australia, Italy, Canada, France, Denmark, United Kingdom
-
Taiho Oncology, Inc.CompletedAdvanced Solid Tumors (Excluding Breast Cancer)United States
-
Hoffmann-La RocheCompleted
-
AstraZenecaDaiichi Sankyo Co., Ltd.Active, not recruitingPart 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer | Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerBelgium, United States, Poland, India, Taiwan, Thailand, Korea, Republic of, Czechia, Russian Federation, United Kingdom, Spain, Australia, Canada, Italy, Netherlands
-
Immatics US, Inc.CompletedCancer | Solid Tumor | Refractory Solid Tumors | Recurrent Solid TumorsUnited States, Germany
-
Memorial Sloan Kettering Cancer CenterAstraZenecaRecruitingSolid Tumor | Metastatic Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Solid Carcinoma | Metastatic TumorUnited States
-
Hoffmann-La RocheRecruitingALK Fusion-positive Solid or CNS TumorsUnited States, Korea, Republic of, China, Spain, Canada, United Kingdom, Australia, Denmark, France, Italy, Germany
-
Hoffmann-La RocheCompletedSolid TumorUnited Kingdom, Netherlands
-
Athenex, Inc.CompletedSolid TumorUnited States, United Kingdom
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors, Excluding Breast CancerUnited States
-
GlaxoSmithKlineCompletedSolid Tumor CancerUnited Kingdom
-
AstraZenecaCompletedRefractory Solid Tumors | Cancer TumorUnited States
-
Chroma TherapeuticsCompletedSafety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid TumoursSolid TumorNetherlands, United Kingdom
-
Stemline Therapeutics, Inc.CompletedStudy of the PI3K Inhibitor SL-901 in Patients With Advanced Solid Tumors With Advanced Solid TumorsAdvanced Solid TumorUnited Kingdom
-
Mina Alpha LimitedActive, not recruitingSolid Tumor, AdultUnited Kingdom
-
iTeos TherapeuticsRecruitingSolid Tumor, AdultBelgium, United Kingdom
-
CephalonCompletedSolid TumorFrance, United Kingdom
-
Byondis B.V.RecruitingSolid TumorBelgium, Italy, Netherlands, United Kingdom
-
Athenex, Inc.TerminatedSolid Tumor, AdultUnited Kingdom
-
Georgetown UniversityImmune System Key LtdRecruitingSolid Tumor | KRAS Mutation-Related TumorsUnited States
-
Cancer Research UKCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited Kingdom
-
AstraZenecaParexelTerminatedAdvanced Solid TumorsUnited Kingdom
-
University of GlasgowCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited Kingdom
-
University of GlasgowCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited Kingdom
-
AbbottGenentech, Inc.CompletedSolid TumorUnited States, Netherlands, United Kingdom
-
Turning Point Therapeutics, Inc.TerminatedAdvanced Solid Tumor | Metastatic Solid Tumor | KRAS Mutation-Related TumorsUnited States
-
University College, LondonCancer Research UKRecruitingCancer | Solid Tumor, AdultUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterRecruitingSolid Tumor | Neuroblastoma | Solid Tumor, Adult | Primary Brain Tumor | Solid Carcinoma | Low-grade Glioma | Central Nervous System Tumor | Refractory Cancer | CNS Tumor, Adult | CNS Tumors | NF1 | Plexiform Neurofibroma | CNS Tumor, Childhood | Optic Pathway Gliomas | MAP Kinase Family Gene MutationUnited States
-
Eli Lilly and CompanyCompletedSolid Tumor | Malignant Solid Tumor | Metastatic TumorGermany, United States, France
-
Cancer Research UKTerminatedUnspecified Adult Solid Tumor, Protocol SpecificUnited Kingdom
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedSolid Tumor | Advanced Solid TumorSpain, United States, Netherlands, United Kingdom
-
Artios Pharma LtdCompletedSolid Tumor, Unspecified, AdultUnited States, United Kingdom
-
Byondis B.V.CompletedSolid TumorUnited Kingdom, Belgium, Netherlands
-
Mateon TherapeuticsCancer Research UKCompleted
-
BeiGeneCompletedAdvanced Solid TumorsUnited Kingdom
-
Chugai Pharma Europe Ltd.CompletedSolid TumorsUnited Kingdom